Delisting Determination, The Nasdaq Stock Market, LLC,
February 4, 2020, Melinta Therapeutics, Inc. The Nasdaq
Stock Market, LLC (the Exchange) has determined to remove
from listing the common stock of Melinta Therapeutics, Inc.
(the Company), effective at the opening of the trading session
on February 14, 2020. Based on review of information provided
by the Company, Nasdaq Staff determined that the Company
no longer qualified for listing on the Exchange pursuant
to Listing Rules 5101, 5110(b), and IM-5101-1.
The Company was notified of the Staff determination on
January 2, 2020. The Company did not appeal the Staff
determination to the Hearings Panel. The Listing Council
did not call the matter for review. The Staff determination
to delist the Company common stock became final on
January 13, 2020.